IR-Med (IRME) Equity Ratio (2020 - 2025)
IR-Med recorded quarterly Equity Ratio of 3.57 in Q2 2025, up 10.17% quarter-over-quarter from 3.98 in Q1 2025, and down 972.69% year-over-year from 0.41 in Q2 2024.
IR-Med's Equity Ratio history runs 6 years deep, the most recent figure standing at 3.57 for Q2 2025.
- In Q2 2025, Equity Ratio fell 972.69% year-over-year to 3.57; the TTM figure through Jun 2025 stood at 3.57 (down 972.69% YoY), while the FY2024 annual figure was 1.17, down 420.59% from the prior year.
- Equity Ratio came in at 3.57 for Q2 2025 at IR-Med, up from 3.98 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.89 in Q3 2021 to a low of 3.98 in Q1 2025.
- A 5-year average of 0.12 and a median of 0.53 in 2024 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio soared 97572.01% in 2022 and sank 2576.73% in 2025, its largest moves.
- IR-Med's Equity Ratio stood at 0.0 in 2021, then jumped by 97572.01% to 0.79 in 2022, then tumbled by 53.57% to 0.37 in 2023, then tumbled by 420.59% to 1.17 in 2024, then slumped by 204.91% to 3.57 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 3.57, 3.98, and 1.17 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | IR-Med | - | - | - | -3.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -3.57 |
| Mar 31, 2025 | -3.98 |
| Dec 31, 2024 | -1.17 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | -0.15 |
| Dec 31, 2023 | 0.37 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.77 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.87 |
| Jun 30, 2022 | 0.86 |
| Mar 31, 2022 | 0.65 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.89 |
| Dec 31, 2020 | 0.67 |